| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/10/1999 | CA2317502A1 Matrix metalloproteinase inhibitors |
| 09/10/1999 | CA2263392A1 Ipriflavone preparation process |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939803A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 09/08/1999 | EP0939757A1 Novel integrin receptor antagonists |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | CN1228083A Arylsulfonylamino hydroxamic acid derivatives |
| 09/08/1999 | CN1228080A Novel immunotherapeutic agents and their use in production of cytokine levels |
| 09/08/1999 | CN1228024A Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/08/1999 | CN1227754A External use medicine for curing prolapse of lumbar intervertebral disc |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948782 Antiinflammatory agent; rheumatic diseases |
| 09/07/1999 | US5948777 Cannabinoid receptor agonists |
| 09/07/1999 | US5948766 Use of tasteless, hydrolyzed collagen and agent containing the same |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948428 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | WO1999024460A3 Dipeptide nitriles |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321642A1 N-¬(substituted five-membered di- or triaza diunsaturated ring)carbonyl|guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938326A1 Synthetic phosphopeptides for treating bone diseases |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227503A Novel device for transdermal administering of trimegestone |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 09/01/1999 | CN1227104A External use Chinese drug powder and its preparing method and medicinal pad |
| 09/01/1999 | CN1044912C Thio-substituted cyclic phosphonate compounds, and its pharmaceutical compositions and use |
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945410 Administered to treat postmanopausal osteoporosis, low bone turnover osteoporosis, osteomalacia and renal osteodystrophy |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/31/1999 | CA2145835C Hydroxamic acid derivatives with tricyclic substitution |
| 08/26/1999 | WO1999042584A1 Apoptosis inducing molecule ii and methods of use |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042130A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | WO1999042107A1 Piperazine derivatives for treating bone deficit conditions |
| 08/26/1999 | WO1999042105A1 Epimorphian compound and its use |
| 08/26/1999 | WO1999042101A1 Dietary control of arachidonic acid metabolism |
| 08/26/1999 | WO1999042075A2 Antibodies against human cd40 |
| 08/26/1999 | WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 08/26/1999 | CA2321973A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | CA2321186A1 Apoptosis inducing molecule ii and methods of use |
| 08/26/1999 | CA2321165A1 Antibodies against human cd40 |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | CA2318959A1 Epimorphian compound and its use |
| 08/26/1999 | CA2288178A1 Piperazine derivatives for treating bone deficit conditions |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors |
| 08/25/1999 | EP0937143A2 Secreted proteins and polynucleotides encoding them |
| 08/25/1999 | EP0937099A1 Oligomers which inhibit the expression of interleukin genes |
| 08/25/1999 | EP0937076A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/25/1999 | EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists |
| 08/25/1999 | EP0937062A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937061A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937060A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937059A1 NOVEL $i(TRANS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937058A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937057A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 08/25/1999 | EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 08/25/1999 | EP0937038A1 Vitamin d analogues |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0936913A1 Oral pharmaceutical preparation containing ibandronat |
| 08/25/1999 | EP0936912A1 Inhibitors of cysteine protease |
| 08/25/1999 | CN1226432A External used Chinese medicine preparation for traumatic injury |
| 08/25/1999 | CN1226424A Slow releasing agent of tuduvanine and its preparing method |
| 08/24/1999 | US5942502 Method of treating diseases resulting from calcium metabolism disorders |
| 08/24/1999 | US5942499 Method of promoting bone growth with hyaluronic acid and growth factors |
| 08/24/1999 | US5942496 Methods and compositions for multiple gene transfer into bone cells |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | CA2248972A1 Novel compounds |
| 08/24/1999 | CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG |
| 08/19/1999 | WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 08/19/1999 | WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/19/1999 | WO1999040926A1 Agents and methods for protection, treatment and repair of connective tissue |
| 08/19/1999 | WO1999040910A1 Anti-inflammatory agents |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1998030590A9 Analogs of parathyroid hormone |
| 08/19/1999 | DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments |
| 08/19/1999 | CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg |
| 08/19/1999 | CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | CA2320285A1 Anti-inflammatory agents |
| 08/19/1999 | CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |